small
molecul
librari
contain
known
bioactiv
compound
screen
antivir
activ
polioviru
pv
use
cellular
fluoresc
reson
energi
transfer
fret
assay
viral
proteas
activ
infect
report
cell
treat
viral
replicationsuppress
compound
examin
via
fluoresc
microscop
h
postinfect
twelv
molecul
show
moder
potent
antivir
activ
concentr
less
primari
screen
three
compound
anisomycin
linol
acid
lycorin
chosen
valid
dosedepend
cytotox
assay
secondari
screen
use
convent
plaqu
assay
conduct
confirm
result
develop
method
use
rapid
screen
molecul
antivir
activ
polioviru
pv
member
genu
enteroviru
famili
picornavirida
use
model
organ
studi
nonenvelop
viru
life
cycl
although
detail
molecular
basi
pv
replic
fulli
understood
clear
viral
replic
depend
interact
host
factor
viral
gene
express
rna
replic
viru
assembl
andino
et
al
belov
et
al
belov
et
al
egger
et
al
howev
specif
function
host
cellular
factor
yet
determin
despit
decad
studi
mechan
viral
replic
develop
systemat
protocol
identifi
factor
modul
viru
life
cycl
minim
advanc
chemic
genom
access
chemic
librari
compound
divers
function
longer
limit
factor
emerg
highthroughput
screen
ht
call
develop
accur
effici
report
system
cellbas
report
assay
identif
small
molecul
suppress
pv
replic
establish
previou
studi
hwang
et
al
cellbas
assay
ideal
develop
highthroughput
methodolog
provid
inform
address
issu
rais
chemicalbas
vitro
studi
cytotox
caus
treatment
drug
transport
effici
cell
effect
dose
target
compound
thu
ideal
develop
highthroughput
methodolog
howev
cellbas
platform
avail
elucid
role
host
factor
viral
replic
remain
limit
attempt
fulfil
demand
effect
screen
protocol
inhibitor
viru
replic
establish
cellular
platform
exploit
potenti
applic
ht
recent
develop
cellular
report
system
use
fluoresc
reson
energi
transfer
fret
viral
proteas
activ
indic
activ
viral
reproduct
hwang
et
al
fret
phenomenon
involv
two
fluorochrom
overlap
emiss
excit
spectra
energi
donor
fluorophor
partial
transfer
acceptor
distanc
two
fluorophor
less
protein
ecfp
enhanc
yellow
fluoresc
protein
eyfp
fret
pair
link
pro
cleavag
sequenc
hwang
et
al
pv
pro
produc
earli
stage
replic
cycl
cao
et
al
cleav
linker
peptid
flank
fret
pair
separ
fluoresc
protein
pair
monitor
use
fluoresc
microscopi
fig
chemic
librari
bioactiv
small
molecul
chosen
demonstr
potenti
usag
establish
cellular
fret
assay
highcont
screen
sinc
compound
chosen
librari
target
specif
cellular
function
approach
suitabl
map
cellular
factor
pathway
contribut
pv
replic
primari
screen
report
cell
seed
plate
cultur
medium
infect
pv
multipl
infect
moi
cultur
medium
remov
aspir
viru
suspens
dmem
one
bioactiv
small
molecul
ad
well
nmethoxysuccinylalaalaprovalchloromethylketon
mpcmk
sigmaaldrich
known
pro
inhibitor
includ
posit
control
fig
sampl
incub
h
c
fix
formaldehyd
pb
room
temperatur
min
sampl
examin
invert
fluoresc
microscop
nikon
eclips
cfp
excit
wavelength
nm
emiss
wavelength
nm
yfp
excit
wavelength
nm
emiss
wavelength
nm
filter
set
compound
test
final
concentr
less
intern
control
includ
infect
report
cell
neg
control
infect
report
cell
treat
mm
mpcmk
posit
control
uninfect
report
cell
comparison
fig
microscopybas
analysi
also
recogn
toxic
compound
screen
basi
cellular
morpholog
chang
due
treatment
primari
screen
identifi
compound
caus
fret
signal
virusinfect
report
cell
retain
indic
potenti
antivir
activ
tabl
posit
compound
includ
molecul
affect
wide
rang
host
cellular
function
gener
protein
synthesi
inhibitor
eg
cycloheximid
calcium
channel
blocker
eg
mode
action
posit
compound
summar
tabl
anisomycin
linol
acid
lycorin
chosen
assay
cytotox
follow
doserespons
test
valid
efficaci
primari
screen
cell
proliferationbas
mtt
assay
chemicon
temecula
ca
use
examin
level
cytotox
due
drug
treatment
mtt
tetrasodium
bromid
base
abil
mitochondri
dehydrogenas
live
cell
cleav
tetrazolium
ring
pale
yellow
mtt
form
dark
blue
formazan
crystal
absorb
light
wavelength
nm
viral
titer
reduct
assay
use
convent
plaqu
assay
conduct
verifi
potenc
select
compound
primari
screen
test
compound
dissolv
dmso
stock
concentr
mm
work
solut
dilut
dmem
achiev
desir
concentr
compound
test
four
concentr
triplic
bgmk
cell
seed
plate
corn
infect
pv
moi
adsorpt
ml
appropri
concentr
test
compound
ad
well
supernat
well
contain
infect
cell
collect
h
incub
viral
titer
sampl
determin
use
plaqu
assay
anisomycin
achiev
log
unit
reduct
viru
titer
neglig
cytotox
fig
anisomycin
origin
discov
peptidyl
transferas
inhibitor
secret
streptomyc
spp
also
potent
activ
mitogenactiv
protein
map
kinas
cascad
barro
et
al
grollman
zinck
et
al
anisomycin
show
strong
inhibit
pv
replic
studi
fig
well
prior
report
ehrenfeld
mani
hazzalin
et
al
linol
acid
polyunsatur
fatti
acid
show
log
unit
reduct
viru
titer
fig
lycorin
caus
log
unit
reduct
viru
titer
sign
cytotox
fig
earlier
studi
demonstr
lycorin
product
inhibitor
found
plant
speci
lycori
narcissu
vrijsen
et
al
exhibit
antivir
pv
replic
herp
simplex
viru
sever
acut
respiratori
syndrom
coronaviru
ieven
et
al
li
et
al
renardnozaki
et
al
anisomycin
lycorin
exhibit
strong
antivir
activ
pv
replic
anisomycin
potent
compound
among
test
howev
linol
acid
signific
pv
inhibitor
condit
test
fig
dosedepend
respons
curv
anisomycin
confirm
robust
develop
protocol
fig
inhibitori
concentr
ic
pv
replic
determin
use
viral
titer
reduct
assay
describ
previous
infect
report
cell
incub
serial
dilut
nm
compound
order
fig
select
posit
compound
cellular
screen
anisomycin
linol
acid
b
lycorin
c
chosen
detail
dosedepend
test
viral
titer
reduct
mtt
assay
cytotox
level
data
point
collect
two
independ
experi
two
replic
within
experi
error
bar
repres
standard
deviat
left
yaxi
viral
titer
log
unit
pfuml
right
yaxi
percentag
inhibit
cellular
prolifer
obtain
accur
ic
nonlinear
regress
appli
fit
curv
use
sigmaplot
systat
softwar
san
jose
ca
viral
titer
cell
without
treatment
defin
origin
viru
concentr
c
c
repres
viru
concentr
anisomycintr
cell
percentag
viral
growth
inhibit
calcul
c
c
c
calcul
ic
anisomycin
nm
neglig
effect
host
protein
synthesi
grollman
posit
compound
primari
screen
cellular
functionspecif
molecul
report
antivir
activ
accord
previou
research
report
cycloheximid
translat
elong
inhibitor
block
gener
viru
replic
due
fact
host
protein
synthesi
impair
upon
drug
treatment
thu
host
cell
fail
support
viru
growth
barton
et
al
potent
pv
replic
inhibitor
brefeldin
block
gtp
cycl
result
disrupt
golgi
complex
also
score
posit
screen
crotti
et
al
chao
et
al
shown
calcium
channel
inhibitor
inhibit
protein
express
lipid
metabol
thought
associ
modul
viru
replic
kapadia
chisari
cherri
et
al
identifi
three
compound
ciglitazon
ppar
agonist
fccp
carbonyl
cyanid
ptrifluoromethoxyphenylhydrazon
mitochondri
uncoupl
linol
acid
target
peroxisom
proliferatorsactiv
receptor
ppar
signal
pathway
involv
signal
transduct
cascad
fatti
acid
lipid
metabol
nedergaard
et
al
latruff
vamecq
addit
studi
also
identifi
small
molecul
involv
pathway
novel
associ
pv
replic
ouabain
trequinsin
tabl
investig
role
compound
pv
replic
need
advanc
understand
mechan
involv
summari
describ
cellular
report
system
target
pv
replic
enabl
rapid
identif
pvspecif
inhibitori
molecul
requir
h
observ
plaqu
form
unit
via
plaqu
assay
incub
time
fluoresc
assay
h
preliminari
data
shown
chang
ecfpeyfp
ratio
measur
use
fluoresc
plate
reader
zfactor
assay
also
amen
highcont
highthroughput
microscopi
autom
sampl
prepar
imag
acquisit
analysi
data
gener
mine
starkuvien
peppertkok
